Detalles de la búsqueda
1.
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 23(3): 445-451, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27914967
2.
"Real-world" data on the efficacy and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma who were treated according to the standard clinical practice: a study of the Greek Myeloma Study Group.
Ann Hematol
; 93(1): 129-39, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23892921
3.
Real-world data on prognosis and outcome of primary plasma cell leukemia in the era of novel agents: a multicenter national study by the Greek Myeloma Study Group.
Blood Cancer J
; 8(3): 31, 2018 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29523783
4.
Report of novel chromosomal abnormalities in a series of 130 chronic lymphocytic leukemia patients studied by classic cytogenetic analysis.
Leuk Lymphoma
; 47(10): 2084-7, 2006 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-17071480
5.
Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response.
Hemasphere
; 5(1): e506, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324952
6.
Large granular lymphocyte leukemia after renal transplantation: an immunologic, immunohistochemical, and genotypic study.
Transplantation
; 83(1): 102-3, 2007 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17220805
7.
Feasibility of an easily applicable method of ZAP-70 measurement in chronic lymphocytic leukemia in the routine flow cytometry setting: A methodological approach.
Ann Hematol
; 85(11): 795-805, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16871389
Resultados
1 -
7
de 7
1
Próxima >
>>